What sector is SCLXW in?

Healthcare, in the Biotechnology industry.

NASDAQ · SCLXWHealthcareBiotechnology

Scilex Holding Company Warrant (SCLXW)

$0.0880+40.35%

Close Sep 25, 2026 · split-adjusted

Sep 25, 2026$0.09▼ 61.74% in range

Sep 29, 2025Low $0.06 · High $0.30Sep 25, 2026

What changed · written from our data

As of Sep 28, 2026

Scilex Holding Company Warrant closed at $0.09 on Sep 25, up 40.35%, 70.4% below its highest close since Nov 11. Volume of 6.7K shares was 1.07× its 20-day average (close to normal).

Split-adjusted performance: -45.0% over one month, -29.0% over six months.

In the quarter ended Jun 30, 2026, revenue was $7.64M, down 22.8% from a year earlier, with a net margin of -1501.3%.

Short interest was 171.3K shares at the Sep 15 settlement, down 3.4% from the prior report (35.5 days to cover).

Market cap—

Revenue · quarter$7.6M−22.8% YoY

Diluted EPS$-16.65—

P/E · TTM—

Net margin-1,501.3%Gross 51.9%

Dividend yieldNone

Range since Nov 110.06 – 0.30−70.4% from high

Volume6.7K1.07× 20-day avg

Volatility · 60d261.2%Annualised

Short % of float—35.5 days to cover

Net cash-$82.5MCash $581.0K

Next earnings—Not scheduled

Split-adjusted performance

1W −2.2%1M −45.0%3M −25.6%6M −29.0%YTD −7.3%1Y —3Y −78.0%5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Biotechnology

Percentile among 139 companies (100 = best)

6-month momentum—

Revenue growth—

Net margin—

Value (low P/E)—

Size—

Industry medians: 6-month return −3.9%, revenue growth +9.0%, net margin −231.7%, P/E 20.2×.

Short interest

Details →

Shares short171.3K−3.4% vs prior

Days to cover35.5Settled Sep 15

% of float—

Short vol. 10d41.4%of daily volume

News about Scilex Holding Company Warrant

All news →

Scilex Holding Company Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLPGlobeNewswire Inc. · Jul 6, 2026▲ Positive Scilex (SCLX) Stock Jumps After Dream Bowl Meme Coin Listing Update: Why Is It Moving?Benzinga · Jun 17, 2026▲ Positive Scilex Holding Company ("Scilex") Announces a Payment Date of June 15, 2026 for the Previously Announced Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity SecuritiesBenzinga · Jun 4, 2026▲ Positive Scilex Holding Company ("Scilex") Announces Its Board of Directors Approved a Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities with a Record Date of June 1, 2026Benzinga · May 22, 2026Neutral Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings LimitedBenzinga · May 5, 2026▲ Positive

Quick answers

What does Scilex Holding Company Warrant do?: Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes.
What sector is SCLXW in?: Healthcare, in the Biotechnology industry.

About Scilex Holding Company Warrant

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

HQ: Palo Alto, CA34 employeesListed Nov 11, 2022scilexholding.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology